Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010–2016 | Zendy

Evans Mpabalwani | Zendy; Chileshe LukwesaMusyani | Zendy; Akakambama Imamba | Zendy; Ruth Nakazwe | Zendy; Belem Matapo | Zendy; Chilweza Muzongwe | Zendy; Trust Mufune | Zendy; Elizabeth Soda | Zendy; Jason M. Mwenda | Zendy; Chelsea S. Lutz | Zendy; Tracy Pondo | Zendy; Fernanda C. Lessa | Zendy

Open Access

Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010–2016

Author(s) -

Evans Mpabalwani,

Chileshe LukwesaMusyani,

Akakambama Imamba,

Ruth Nakazwe,

Belem Matapo,

Chilweza Muzongwe,

Trust Mufune,

Elizabeth Soda,

Jason M. Mwenda,

Chelsea S. Lutz,

Tracy Pondo,

Fernanda C. Lessa

Publication year - 2019

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciz456

Subject(s) - medicine , pneumococcal conjugate vaccine , meningitis , pneumonia , pediatrics , streptococcus pneumoniae , bacterial meningitis , conjugate vaccine , pneumococcal pneumonia , immunology , antibiotics , immunization , microbiology and biotechnology , antibody , biology

Pneumococcus is a leading cause of pneumonia and meningitis. Zambia introduced a 10-valent pneumococcal conjugate vaccine (PCV10) in July 2013 using a 3-dose primary series at ages 6, 10, and 14 weeks with no booster. We evaluated the impact of PCV10 on meningitis and pneumonia hospitalizations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research